BRIEF-Inovio pharma up 12 percent premarket after preclinical trial results of dna vaccine

NEW YORK, Nov 20 (Reuters) - Inovio Pharmaceuticals Inc (INO) : * Pharma up 12 percent to $2.15 in premarket after preclinical trial results of dna vaccine


(c) Reuters 2013. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.